Alzheimer’s Disease:New Therapeutic Targets and Approaches
Dr. Mark Forman discusses early stage results of a drug that targets a well known feature of Alzheimer’s in the brain – beta amyloid protein.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Dr. Mark Forman discusses early stage results of a drug that targets a well known feature of Alzheimer’s in the brain – beta amyloid protein.